ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18 F-Choline PET/CT for the Prediction of Biochemical Recurrence after Metastasis-Directed Therapy in Patients with Oligometastatic Prostate Cancer.
Luca UrsoCorrado CittantiLuigi MancoNaima OrtolanFrancesca BorgiaAntonio MalorgioGiovanni ScribanoEdoardo MastellaMassimo GuidoboniAntonio StefanelliAlessandro TurraMirco BartolomeiPublished in: Diagnostics (Basel, Switzerland) (2024)
F-choline PET/CT can accurately predict BCR after MDT in oligorecurrent PCa patients. If validated externally, ML Models could improve the selection of oligorecurrent PCa patients for treatment with MDT.